TORONTO and HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage […]
Wilmington, Del., April 01, 2025 (GLOBE NEWSWIRE) — Ashland has completed a 10-million-dollar expansion of its pharmaceutical manufacturing plant in […]